
MediWound Ltd.: updates and filings
Price
$13.59
November 20, 2026Market cap $174M
What Ploutos Investor adds for MediWound
Part of Ploutos Investor, €9.99 a month
- The full history: 11 fiscal years, from 2015
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 12, 2026Current report (foreign company)Form6-K
- Nov 5, 2026Current report (foreign company)Form6-K
- Aug 28, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Current report (foreign company)Form6-K
- May 27, 2026Current report (foreign company)Form6-K
- May 15, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 6, 2026Current report (foreign company)Form6-K
- Apr 2, 2026Current report (foreign company)Form6-K
- Mar 30, 2026Current report (foreign company)Form6-K
- Mar 5, 2026Shares registered for employeesFormS-8
- Mar 5, 2026Annual report (foreign company)for the period to Dec 31, 2025Form20-F
- Mar 5, 2026Current report (foreign company)Form6-K
- Feb 19, 2026Current report (foreign company)Form6-K
- Feb 17, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 11, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 15, 2026Current report (foreign company)Form6-K
- Jan 12, 2026Current report (foreign company)Form6-K
- Nov 20, 2025Current report (foreign company)Form6-K
- Nov 14, 2025Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 12, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 3, 2025Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 12, 2026 | 6-K | Current report (foreign company) | Document |
| Nov 5, 2026 | 6-K | Current report (foreign company) | Document |
| Aug 28, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | 6-K | Current report (foreign company) | Document |
| May 27, 2026 | 6-K | Current report (foreign company) | Document |
| May 15, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 6, 2026 | 6-K | Current report (foreign company) | Document |
| Apr 2, 2026 | 6-K | Current report (foreign company) | Document |
| Mar 30, 2026 | 6-K | Current report (foreign company) | Document |
| Mar 5, 2026 | S-8 | Shares registered for employees | Document |
| Mar 5, 2026 | 20-F | Annual report (foreign company)for the period to Dec 31, 2025 | Document |
| Mar 5, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 19, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 17, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 11, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 15, 2026 | 6-K | Current report (foreign company) | Document |
| Jan 12, 2026 | 6-K | Current report (foreign company) | Document |
| Nov 20, 2025 | 6-K | Current report (foreign company) | Document |
| Nov 14, 2025 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 12, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 3, 2025 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 23, 2013.
The full analysis
What do MediWound's filings show?
The filings are where every one of MediWound's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.